Pacific Edge Limited Company Review & Valuation

PEB
New Zealand Stock Exchange
Latest Price
10.60NZD

About Pacific Edge Limited

Pacific Edge Limited, a cancer diagnostic company, develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand and internationally.

It operates through two segments, Commercial and Research.

The company offers Cxbladder, a suite of non-invasive laboratory tests for the deduction and management of bladder cancer.

It is also developing Cxbladder Resolve, a product designed to identify high grade or late stage bladder cancer and provide increased clinical resolution; and Cxcolorectal (prognosis Gen II), a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers, which are in clinical and user trials.

In addition, the company is developing products for gastric, melanoma, and endometrial cancers, which are in pre-clinical trials.

Pacific Edge Limited was founded in 2001 and is headquartered in Dunedin, New Zealand.

Industry
Diagnostics & Research
HQ Location
Dunedin, New Zealand

Stock Price

Price data not available for Pacific Edge Limited.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl